New voter surge in early voting could sway battleground states in 2024 US presidential election    Civil Defense urges caution amid forecast of heavy rain to hit most Saudi regions until Monday    What's in it for FinTech startups in events like Biban24    Al Nassr and Al Hilal share points in intense Riyadh Derby draw    ImpaQ: Riyadh to host first Impact Makers Forum in December    Saudi Arabia ranks 12th globally in international visitor spending in 2023    SFDA chief discusses investment opportunities in food and pharmaceutical sectors with Chinese companies    Riyadh's Sports Boulevard receives Platinum ActiveScore certifications    Saudi Arabia refutes claims of rising worker fatalities, highlighting low work-related death rates    US says around 8,000 troops from North Korea are stationed in Russia's Kursk region    Spain mourns as death toll passes 150 in catastrophic floods    Seven killed in Israel in deadliest Hezbollah rocket strikes in months    Cyclists on phones face jail under Japan's new traffic laws    Hidden sugars in Asia's baby food spark concerns    Saleh Al Shehri strike seals Al Ittihad's Sea Derby win over Al Ahli    HONOR unveils pre-order of the stunning HONOR MagicBook Art 14 Featuring an ultra-slim design, HONOR Eye Comfort Display and AI Cross-OS WorkStation    Derby Week makes its debut in the Roshn Saudi League    Al Nassr eliminated from King's Cup after a defeat to Al Taawoun    Teri Garr, Young Frankenstein and Tootsie star, dies at 79    Indonesia Days event celebrates cultural diversity at Al Suwaidi Park    India puts blockbuster Pakistani film on hold    The Vikings and the Islamic world    Filipino pilgrim's incredible evolution from an enemy of Islam to its staunch advocate    Muted Eid celebrations for millions of Nigerian Muslims    Exotic Taif Roses Simulation Performed at Taif Rose Festival    Asian shares mixed Tuesday    Weather Forecast for Tuesday    Saudi Tourism Authority Participates in Arabian Travel Market Exhibition in Dubai    Minister of Industry Announces 50 Investment Opportunities Worth over SAR 96 Billion in Machinery, Equipment Sector    HRH Crown Prince Offers Condolences to Crown Prince of Kuwait on Death of Sheikh Fawaz Salman Abdullah Al-Ali Al-Malek Al-Sabah    HRH Crown Prince Congratulates Santiago Peña on Winning Presidential Election in Paraguay    SDAIA Launches 1st Phase of 'Elevate Program' to Train 1,000 Women on Data, AI    41 Saudi Citizens and 171 Others from Brotherly and Friendly Countries Arrive in Saudi Arabia from Sudan    Saudi Arabia Hosts 1st Meeting of Arab Authorities Controlling Medicines    General Directorate of Narcotics Control Foils Attempt to Smuggle over 5 Million Amphetamine Pills    NAVI Javelins Crowned as Champions of Women's Counter-Strike: Global Offensive (CS:GO) Competitions    Saudi Karate Team Wins Four Medals in World Youth League Championship    Third Edition of FIFA Forward Program Kicks off in Riyadh    Evacuated from Sudan, 187 Nationals from Several Countries Arrive in Jeddah    SPA Documents Thajjud Prayer at Prophet's Mosque in Madinah    SFDA Recommends to Test Blood Sugar at Home Two or Three Hours after Meals    SFDA Offers Various Recommendations for Safe Food Frying    SFDA Provides Five Tips for Using Home Blood Pressure Monitor    SFDA: Instant Soup Contains Large Amounts of Salt    Mawani: New shipping service to connect Jubail Commercial Port to 11 global ports    Custodian of the Two Holy Mosques Delivers Speech to Pilgrims, Citizens, Residents and Muslims around the World    Sheikh Al-Issa in Arafah's Sermon: Allaah Blessed You by Making It Easy for You to Carry out This Obligation. Thus, Ensure Following the Guidance of Your Prophet    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Health experts give green light to Janssen COVID jab, allay clotting concerns
Published in The Saudi Gazette on 18 - 03 - 2021

The Janssen COVID-19 vaccine was publicly approved for international use on Wednesday by the UN health agency expert advisory board, SAGE, which allayed concerns over clotting events being associated by some countries, without definitive evidence, with coronavirus jabs.
In a virtual press conference from Geneva, SAGE hailed the one-dose Janssen shot — produced by a Johnson & Johnson subsidiary — as a safe and lifesaving addition to the three other vaccines it has already approved for use: Pfizer, Moderna, and AstraZeneca.
The expert panel also noted that clotting episodes - also known as hypercoagulable events - were a symptom of COVID-19, amid the suspension of the AstraZeneca/Oxford vaccine by several European countries, pending scientific review.
'These are lifesaving products'
"The world is in a place where there is insufficient supply to meet the requirements of people who need to be vaccinated; clearly, any of these vaccines are lifesaving products", said Dr. Kate O'Brien, Director, Department of Immunization, Vaccines, and Biologicals at the World Health Organization (WHO).
She insisted that the vaccines "need to be used as quickly as we can get them deployed. People can have confidence in their safety and efficacy and in the quality of the manufacture of the products."
During trials for the Janssen vaccine involving nearly 44,000 people, 10 of the 22,000 people who received the blank dose developed a blood clot — or thrombo-embolic events — while 14 of the remaining 22,000 who were inoculated, developed a clot.
"This is about the same", for both groups said Dr. Annelies Wilder-Smith, the SAGE technical adviser. "There's a slight imbalance, but it's still not statistically significant,"
No evidence of clots related to vaccines
"As for the vaccine itself, we have not seen it in a trial, there's no reason to think and no biological causability as far we understand now, that the vaccine could cause thrombo-embolic events itself. However, we have to be open for new events, and we have to take it seriously."
Dr. Wilder-Smith explained that those recruited for vaccine testing were intentionally chosen because they were people who were "at high risk" of developing blood clots.
"COVID really pre-disposes patients to a hypercoagulable state where indeed many of the deaths that we see in the severe cases are due to thromboembolic events", Dr. Wilder-Smith said, ahead of an expected announcement by the European Medical Agency (EMA) on the issue on Thursday.
In a statement released on Wednesday specifically addressing the AstraZeneca suspension by some European nations, the agency said it was "good practice" to investigate the possible linkages, that the benefits of the vaccine "outweigh its risks" and WHO "recommends that vaccinations continue."
Infections heading up
The development comes amid a rise in new cases of coronavirus infection worldwide, increasing by 10 percent in the past week, to more than three million new reported cases.
WHO reported on Wednesday that after peaking in early January 2021 - when there were just under five million cases a week - new cases then declined to around 2.5 million in the week commencing Feb. 15, 2021.
But the past three weeks have seen cases increasing again.
This week, the Americas and Europe continue to account for more than 80 percent of new cases and new deaths, with rises in new cases in all regions - apart from Africa, where they remained the same as last week.
As of March 17, 2021, there have been 120,164,106 confirmed cases of COVID-19, including 2,660,422 deaths, reported to WHO.
More than 363,000,000 vaccine doses have been administered globally. — UN news


Clic here to read the story from its source.